arrow
Back
M

Mark A. Lemmon

yale university

87H-index
335Paper Count
3.4WCitation Count
Published Papers 109
Publication Date
The role of kinase domain dimerization in EGFR activation
err2025-12-19
err0
PREAI
errZaritza O. Petrova; Long Han; Yuko Tsutsui; Joshua B. Sheetz; Kumar D. Ashtekar; Mark A. Lemmon
errShare
errSave
Allosteric activation of the co-receptor BAK1 by the EFR receptor kinase initiates immune signaling
err2024-07-19
err5
errOAAI
errMuehlenbeck, Henning; Tsutsui, Yuko; Lemmon, Mark A.; Bender, Kyle W.; Zipfel, Cyril
errShare
errSave
Distinct interactions stabilize EGFR dimers and higher-order oligomers in cell membranes
err2024-01-01
err2
errOAAI
errMudumbi, Krishna C.; Burns, Eric A.; Schodt, David J.; Petrova, Zaritza O.; Kiyatkin, Anatoly; Kim, Lucy W.; Mangiacapre, Emma M.; Ortiz-Caraveo, Irais; Ortiz, Hector Rivera; Hu, Chun; Ashtekar, Kumar D.; Lidke, Keith A.; Lidke, Diane S.; Lemmon, Mark A.
errShare
errSave
Glycoproteomic landscape and structural dynamics of TIM family immune checkpoints enabled by mucinase SmE
err2023-10-04
err11
errOAAI
errChongsaritsinsuk, Joann; Steigmeyer, Alexandra D.; Mahoney, Keira E.; Rosenfeld, Mia A.; Lucas, Taryn M.; Smith, Courtney M.; Li, Alice; Ince, Deniz; Kearns, Fiona L.; Battison, Alexandria S.; Hollenhorst, Marie A.; Shon, D. Judy; Tiemeyer, Katherine H.; Attah, Victor; Kwon, Catherine; Bertozzi, Carolyn R.; Ferracane, Michael J.; Lemmon, Mark A.; Amaro, Rommie E.; Malaker, Stacy A.
errShare
errSave
Circulating tumor DNA reveals mechanisms of lorlatinib resistance in patients with relapsed/refractory ALK-driven neuroblastoma
err2023-05-05
err17
errOAAI
errBerko, Esther R.; Witek, Gabriela M.; Matkar, Smita; Petrova, Zaritza O.; Wu, Megan A.; Smith, Courtney M.; Daniels, Alex; Kalna, Joshua; Kennedy, Annie; Gostuski, Ivan; Casey, Colleen; Krytska, Kateryna; Gerelus, Mark; Pavlick, Dean; Ghazarian, Susan; Park, Julie R.; Marachelian, Araz; Maris, John M.; Goldsmith, Kelly C.; Radhakrishnan, Ravi; Lemmon, Mark A.; Mosse, Yael P.
errShare
errSave
Efficacy of Osimertinib in Patients with Lung Cancer Positive for Uncommon EGFR Exon 19 Deletion Mutations
err2023-03-13
err10
errOAAI
errGrant, Michael J.; V. Aredo, Jacqueline; Starrett, Jacqueline H.; Stockhammer, Paul; van Rosenburgh, Iris K. van Alderwerelt; Wurtz, Anna; Piper-Valillo, Andrew J.; Piotrowska, Zofia; Falcon, Christina; Yu, Helena A.; Aggarwal, Charu; Scholes, Dylan; Patil, Tejas; Nguyen, Christina; Phadke, Manali; Li, Fang -Yong; Neal, Joel; Lemmon, Mark A.; Walther, Zenta; Politi, Katerina; Goldberg, Sarah B.
errShare
errSave
Biochemical and structural basis for differential inhibitor sensitivity of EGFR with distinct exon 19 mutations
err2022-11-10
err14
errOAAI
errvan Rosenburgh, Iris K. van Alderwerelt; Lu, David M.; Grant, Michael J.; Stayrook, Steven E.; Phadke, Manali; Walther, Zenta; Goldberg, Sarah B.; Politi, Katerina; Lemmon, Mark A.; Ashtekar, Kumar D.; Tsutsui, Yuko
errShare
errSave
errShare
errSave
ROR and RYK extracellular region structures suggest that receptor tyrosine kinases have distinct WNT-recognition modes
err2021-10-01
err15
errOAAI
errShi, Fumin; Mendrola, Jeannine M.; Sheetz, Joshua B.; Wu, Neo; Sommer, Anselm; Speer, Kelsey F.; Noordermeer, Jasprina N.; Kan, Zhong-Yuan; Perry, Kay; Englander, S. Walter; Stayrook, Steven E.; Fradkin, Lee G.; Lemmon, Mark A.
errShare
errSave
Phosphatidylserine binding directly regulates TIM-3 function
err2021-09-14
err26
errOAAI
errSmith, Courtney M.; Li, Alice; Krishnamurthy, Nithya; Lemmon, Mark A.
errShare
errSave
EComputational studies of anaplastic lymphoma kinase mutations reveal common mechanisms of oncogenic activation
err2021-03-04
err5
errOAAI
errPatil, Keshav; Jordan, Earl Joseph; Park, Jin H.; Suresh, Krishna; Smith, Courtney M.; Lemmon, Abigail A.; Mosse, Yael P.; Lemmon, Mark A.; Radhakrishnan, Ravi
errShare
errSave
errShare
errSave
Kinetics of receptor tyrosine kinase activation define ERK signaling dynamics
err2020-08-18
err41
errOAAI
errKiyatkin, Anatoly; van Rosenburgh, Iris K. van Alderwerelt; Klein, Daryl E.; Lemmon, Mark A.
errShare
errSave
Structural Insights into Pseudokinase Domains of Receptor Tyrosine Kinases
err2020-08-01
err65
errOAAI
errSheetz, Joshua B.; Mathea, Sebastian; Karvonen, Hanna; Malhotra, Ketan; Chatterjee, Deep; Niininen, Wilhelmiina; Perttila, Robert; Preuss, Franziska; Suresh, Krishna; Stayrook, Steven E.; Tsutsui, Yuko; Radhakrishnan, Ravi; Ungureanu, Daniela; Knapp, Stefan; Lemmon, Mark A.
errShare
errSave
Drug Sensitivity and Allele Specificity of First-Line Osimertinib Resistance EGFR Mutations
err2020-05-15
err49
errOAAI
errStarrett, Jacqueline H.; Guernet, Alexis A.; Cuomo, Maria Emanuela; Poels, Kamrine E.; van Rosenburgh, Iris K. van Alderwerelt; Nagelberg, Amy; Farnsworth, Dylan; Price, Kristin S.; Khan, Hina; Ashtekar, Kumar Dilip; Gaefele, Mmaserame; Ayeni, Deborah; Stewart, Tyler F.; Kuhlmann, Alexandra; Kaech, Susan M.; Unni, Arun M.; Homer, Robert; Lockwood, William W.; Michor, Franziska; Goldberg, Sarah B.; Lemmon, Mark A.; Smith, Paul D.; Cross, Darren A. E.; Politi, Katerina
errShare
errSave
Drug Sensitivity and Allele-specificity of First-line Osimertinib Resistance EGFR Mutations
err2020-04-20
err0
PREAI
errStarrett, Jacqueline; Guernet, Alexis; Cuomo, Maria; Poels, Kamrine; van Rosenburgh, Iris; Nagelberg, Amy; Farnsworth, Dylan; Price, Kristin; Khan, Hina; Ashtekar, Kumar; Gaefele, Mmaserame; Ayeni, Deborah; Stewart, Tyler; Kuhlmann, Alexandra; Kaech, Susan; Unni, Arun; Homer, Robert; Lockwood, William; Michor, Franziska; Goldberg, Sarah; Lemmon, Mark; Smith, Paul; Cross, Darren; Politi, Katerina
errShare
errSave
Neuregulin Signaling Is a Mechanism of Therapeutic Resistance in Head and Neck Squamous Cell Carcinoma
err2019-11-01
err11
errOAAI
errBaro, Marta; Lopez Sambrooks, Cecilia; Burtness, Barbara A.; Lemmon, Mark A.; Contessa, Joseph N.
errShare
errSave